| 1 |
Utility of Immunohistochemistry for MUC4 and GATA3 to Aid in the Distinction of Pleural Sarcomatoid Mesothelioma From Pulmonary Sarcomatoid Carcinoma.
61
|
Terra SBSP...Boland JM
|
33501493 |
2021 |
| 2 |
Intermittent Superior Vena Cava Syndrome Secondary to Malignant Pericardial Mesothelioma.
61
|
Alwusaibie SA...Alsaeed SA
|
33489524 |
2020 |
| 3 |
Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1.
61
|
Zaleski M...Moran CA
|
33176261 |
2020 |
| 4 |
Primary Intrathoracic Sarcomas: A Review of Cross-sectional Imaging and Pathology.
61
|
Chahal A...Sonavane SK
|
33196594 |
2020 |
| 5 |
The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
61
|
Prabhakaran S...Klebe S
|
32888937 |
2020 |
| 6 |
ALPPL2 Is a Highly Specific and Targetable Tumor Cell Surface Antigen.
61
|
Su Y...Liu B
|
32868383 |
2020 |
| 7 |
Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma.
61
|
Nakashima Y...Ishikawa Y
|
32777673 |
2020 |
| 8 |
Heterologous sarcomatoid pleural mesothelioma with osteosarcomatous differentiation: a report of autopsy case that accomplished trimodality therapy and review of the literature.
61
|
Itano H...Kobayashi T
|
31372931 |
2020 |
| 9 |
Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma.
61
|
Brockwell NK...Parker BS
|
32676326 |
2020 |
| 10 |
Utility of Immunohistochemistry for MUC4 and GATA3 to Aid in the Distinction of Pleural Sarcomatoid Mesothelioma From Pulmonary Sarcomatoid Carcinoma.
61
|
Terra SBSP...Boland JM
|
32589069 |
2020 |
| 11 |
Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center.
61
|
Galateau Salle F...Girard N
|
32165206 |
2020 |
| 12 |
Overexpression of miR-199/214 is a distinctive feature of iron-induced and asbestos-induced sarcomatoid mesothelioma in rats.
61
|
Okazaki Y...Toyokuni S
|
32248600 |
2020 |
| 13 |
The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype.
61
|
Kandasamy S...Eckert RL
|
31732616 |
2020 |
| 14 |
Pleural sarcomatoid mesothelioma with an interstitial growth pattern.
61
|
Miyakawa K...Tanino MA
|
31898836 |
2020 |
| 15 |
Expression of V-set immunoregulatory receptor in malignant mesothelioma.
61
|
Chung YS...Shim HS
|
31363159 |
2020 |
| 16 |
Peritoneal sarcomatoid mesothelioma in a sika deer.
61
|
Matsuda K...Sano Y
|
31413229 |
2019 |
| 17 |
Prostate Carcinoma and Pleural Mesothelioma: An Extremely Rare Co-occurrence.
61
|
Soni TP...Kucha N
|
31316876 |
2019 |
| 18 |
Revisiting localized malignant mesothelioma.
61
|
Mann S...Kalhor N
|
30798074 |
2019 |
| 19 |
Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations.
61
|
Chapel DB...Krausz T
|
30315275 |
2019 |
| 20 |
Impact on survival of nuclear atypia in epithelioid malignant mesothelioma.
61
|
Mlika M...Mezni F
|
31038719 |
2019 |
| 21 |
Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?
61
|
Kim S...Hsu CC
|
30278171 |
2019 |
| 22 |
[Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
61
|
Mlika M...Mezni F
|
30293912 |
2018 |
| 23 |
A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.
61
|
Kinoshita Y...Nabeshima K
|
30429020 |
2018 |
| 24 |
Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes.
61
|
Churg A...Galateau-Salle F
|
30268487 |
2018 |
| 25 |
Sarcomatoid mesothelioma of tunica vaginalis testis in the right scrotum of a dog.
61
|
Son NV...Nakayama H
|
29794371 |
2018 |
| 26 |
Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma.
61
|
Nader JS...Pouliquen DL
|
29662647 |
2018 |
| 27 |
How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab.
61
|
Mlika M...Mezni FE
|
29757709 |
2018 |
| 28 |
Invasive sarcomatoid mesothelioma resulting in spinal cord compression: case report.
61
|
Farthing M...Muthukumar D
|
30363152 |
2018 |
| 29 |
Large primary pleural synovial sarcoma with severe dyspnea: a case report.
61
|
Yamaki M...Noriyuki T
|
28205183 |
2017 |
| 30 |
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
61
|
Marchevsky AM...Galateau-Salle F
|
28782639 |
2017 |
| 31 |
[Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].
61
|
Wei MC...Yang SJ
|
28810297 |
2017 |
| 32 |
Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma.
61
|
Pouliquen DL...Gregoire M
|
28915695 |
2017 |
| 33 |
Primary malignant pericardial sarcomatoid mesothelioma: An autopsy report.
61
|
Muta H...Otsubo H
|
28463437 |
2017 |
| 34 |
MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
61
|
Amatya VJ...Takeshima Y
|
28128276 |
2017 |
| 35 |
Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.
61
|
Muscella A...Marsigliante S
|
28704484 |
2017 |
| 36 |
Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
61
|
Ascoli V...Forastiere F
|
27485167 |
2016 |
| 37 |
Dual preventive benefits of iron elimination by desferal in asbestos-induced mesothelial carcinogenesis.
61
|
Jiang L...Toyokuni S
|
27088640 |
2016 |
| 38 |
Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor.
61
|
Kim KC...Vo HP
|
27293862 |
2016 |
| 39 |
[Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma].
61
|
Kishimoto T...Nishi H
|
27210080 |
2016 |
| 40 |
Sarcomatoid mesothelioma: future advances in diagnosis, biomolecular assessment, and therapeutic options in a poor-outcome disease.
61
|
Galetta D...Fico M
|
26108245 |
2016 |
| 41 |
An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
61
|
Klebe S...Henderson DW
|
26281863 |
2016 |
| 42 |
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
61
|
Galateau-Salle F...World Health Organization Committee for Tumors of the Pleura
|
26811225 |
2016 |
| 43 |
Sarcomatoid Type Primary Pericardial Mesothelioma with a Long-term Survival after the Onset of Cardiac Tamponade.
61
|
Saisho C...Hoshino T
|
27803412 |
2016 |
| 44 |
Biphasic Malignant Pleural Mesothelioma Masquerading as a Primary Skeletal Tumor.
61
|
Gleason JB...Diacovo MJ
|
27660729 |
2016 |
| 45 |
Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma.
61
|
Suzawa K...Miyoshi S
|
26870271 |
2016 |
| 46 |
Infant pleuropulmonary blastoma: report of a rare case and review of literature.
61
|
Zhang H...Wang J
|
26722577 |
2015 |
| 47 |
FISH analysis of intrapulmonary malignant mesothelioma without a clinically detectable primary pleural lesion: an autopsy case.
61
|
Hasegawa M...Hiroshima K
|
25425731 |
2014 |
| 48 |
Reproducibility of histological subtyping of malignant pleural mesothelioma.
61
|
Brcic L...Seiwerth S
|
25300229 |
2014 |
| 49 |
Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials.
61
|
Mansfield AS...Peikert T
|
25217189 |
2014 |
| 50 |
Connective tissue growth factor and β-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma.
61
|
Jiang L...Toyokuni S
|
24839947 |
2014 |
